Open AccessCharacterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor
Author(s) -
Stephanie Schwartz,
Nidhi Patel,
Tyler A. Longmire,
Pushpa Jayaraman,
Xiaomo Jiang,
Hongbo Lu,
Lisa Baker,
Janelle Velez,
Radha Ramesh,
AnneSophie Wavreille,
Mélanie Verneret,
Hong Fan,
Tiancen Hu,
Fangmin Xu,
John A. Taraszka,
Marc R. Pelletier,
Joy Miyashiro,
Mikael L. Rinne,
Glenn Dranoff,
Catherine Sabatos-Peyton,
Viviana Cremasco
Publication year - 2022
Publication title -
immunotherapy advances
Language(s) - English
Resource type - Journals
ISSN - 2732-4303
DOI - 10.1093/immadv/ltac019
Subject(s) - myeloid , immunotherapy , monoclonal antibody , cytokine , antibody , immune system , t cell , biology , immunology , cancer research , chemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom